Cargando…

Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer

Triple-negative breast cancer (TNBC) is the deadliest form of breast cancer. Unlike other types of breast cancer that can be effectively treated by targeted therapies, no such targeted therapy exists for all TNBC patients. The ADAR1 enzyme carries out A-to-I editing of RNA to prevent sensing of endo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kung, Che-Pei, Cottrell, Kyle A., Ryu, Sua, Bramel, Emily R., Kladney, Raleigh D., Bross, Emily A., Freeman, Eric C., Sabloak, Thwisha, Maggi, Leonard, Weber, Jason D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796950/ https://www.ncbi.nlm.nih.gov/pubmed/33110236 http://dx.doi.org/10.1038/s41388-020-01515-5

Ejemplares similares

3174 Tumor suppressors p53 and ARF control oncogenic potential of triple-negative breast cancer cells by regulating RNA editing enzyme ADAR1
por: Kung, Che-Pei, et al.
Publicado: (2019)

2213 Tumor suppressors p53 and ARF control oncogenic potential of triple-negative breast cancer cells by regulating RNA editing enzyme ADAR1
por: Kung, Che-Pei, et al.
Publicado: (2018)

Induction of viral mimicry upon loss of DHX9 and ADAR1 in breast cancer cells
por: Cottrell, Kyle A., et al.
Publicado: (2023)

8-Azaadenosine and 8-Chloroadenosine are not Selective Inhibitors of ADAR
por: Cottrell, Kyle A., et al.
Publicado: (2021)

Cathepsin K-Cre Causes Unexpected Germline Deletion of Genes in Mice
por: Winkeler, Crystal L., et al.
Publicado: (2012)

The Role of RNA Editing in Cancer Development and Metabolic Disorders
por: Kung, Che-Pei, et al.
Publicado: (2018)

The ADAR protein family
por: Savva, Yiannis A, et al.
Publicado: (2012)

The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms
por: Kleinova, Renata, et al.
Publicado: (2023)

Complex regulation of ADAR-mediated RNA-editing across tissues
por: Huntley, Melanie A., et al.
Publicado: (2016)

Promoting RNA editing by ADAR attraction
por: Danan-Gotthold, Miri, et al.
Publicado: (2017)

ADAR RNA editing below the backbone
por: Keegan, Liam, et al.
Publicado: (2017)

Functional conservation in human and Drosophila of Metazoan ADAR2 involved in RNA editing: loss of ADAR1 in insects
por: Keegan, Liam P., et al.
Publicado: (2011)

Optimal guideRNAs for re-directing deaminase activity of hADAR1 and hADAR2 in trans
por: Schneider, Marius F., et al.
Publicado: (2014)

ADAR1 restricts LINE-1 retrotransposition
por: Orecchini, Elisa, et al.
Publicado: (2017)

A rADAR defense against RNAi
por: Pasquinelli, Amy E.
Publicado: (2018)

Adar3 Is Involved in Learning and Memory in Mice
por: Mladenova, Dessislava, et al.
Publicado: (2018)

ADAR1-mediated regulation of melanoma invasion
por: Nemlich, Yael, et al.
Publicado: (2018)

ADAR1 Editing and its Role in Cancer
por: Xu, Li-Di, et al.
Publicado: (2018)

ADAR Editing in Viruses: An Evolutionary Force to Reckon with
por: Piontkivska, Helen, et al.
Publicado: (2021)

Evidence for multiple, distinct ADAR-containing complexes in Xenopus laevis
por: Schweidenback, Caterina T.H., et al.
Publicado: (2015)

ADAR1- and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism
por: Widmark, Albin, et al.
Publicado: (2022)

Insights on the Pathogenesis of Aneurysm through the Study of Hereditary Aortopathies
por: Creamer, Tyler J., et al.
Publicado: (2021)

Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs
por: Vogel, Paul, et al.
Publicado: (2018)

Identification of five novel variants of ADAR1 in dyschromatosis symmetrica hereditaria by next-generation sequencing
por: Ma, Qian, et al.
Publicado: (2023)

The rise and fall of an ancient Adélie penguin ‘supercolony’ at Cape Adare, Antarctica
por: Emslie, Steven D., et al.
Publicado: (2018)

The C. elegans neural editome reveals an ADAR target mRNA required for proper chemotaxis
por: Deffit, Sarah N, et al.
Publicado: (2017)

Predicting sites of ADAR editing in double-stranded RNA
por: Eggington, Julie M., et al.
Publicado: (2011)

ADAR mediates differential expression of polycistronic microRNAs
por: Chawla, Geetanjali, et al.
Publicado: (2014)

The origin of the ADAR gene family and animal RNA editing
por: Grice, Laura F, et al.
Publicado: (2015)

RNA Editing, ADAR1, and the Innate Immune Response
por: Wang, Qingde, et al.
Publicado: (2017)

Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs
por: Walkley, Carl R., et al.
Publicado: (2017)

ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity
por: Lamers, Mart M., et al.
Publicado: (2019)

Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma
por: Tusup, Marina, et al.
Publicado: (2021)

ADARs act as potent regulators of circular transcriptome in cancer
por: Shen, Haoqing, et al.
Publicado: (2022)

ADAR1: a mast regulator of aging and immunity
por: Zhang, Yigan, et al.
Publicado: (2023)

It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
por: Kung, Che-Pei, et al.
Publicado: (2022)

ADAR1 Alleviates Inflammation in a Murine Sepsis Model via the ADAR1-miR-30a-SOCS3 Axis
por: Shangxun, Zhou, et al.
Publicado: (2020)

Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma
por: Sharpnack, Michael F., et al.
Publicado: (2017)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

CIP2A is a target of bortezomib in human triple negative breast cancer cells
por: Tseng, Ling-Ming, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v5e1nap2a069rnf18rvrl512cl